Reckitt Benckiser: UBS maintains 'buy' rating
(CercleFinance.com) - UBS reinstates its 'buy' recommendation on Reckitt Benckiser shares, maintaining its target price for them at 8,000p, which represents upside potential of 43% for the UK consumer staples group's shares.
"Consumer Healthcare reporting some strong sequential improvement in Q2 evidencing sound fundamentals and compelling prospects," the broker summarises.
Copyright (c) 2021 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.